Regulation And Legal
AstraZeneca Pharma India Receives 64 ESG Rating
Crisil ESG Ratings assigned AstraZeneca Pharma India an ESG rating of 64 for fiscal year 2026 based on public information.
The rating was prepared independently without company engagement, as disclose
